Cat. #151735
Anti-Urothelium [LBS19]
Cat. #: 151735
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Urothelium
Class: Monoclonal
Application: IHC
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Jenny Southgate ; Ludwik Trejdosiewicz
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Urothelium [LBS19]
- Research fields: Cell biology
- Clone: LBS19
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IHC
- Description: May be valuable as a probe in the study of normal differentiation and malignant transformation in human urothelial cells. Reacts with all human epithelium cell lines.
- Immunogen: Human urothelial carcinoma-derived RT112 cells
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: Urothelium
- Target background: May be valuable as a probe in the study of normal differentiation and malignant transformation in human urothelial cells. Reacts with all human epithelium cell lines.
Applications
- Application: IHC
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Matthews et al. 1985. Biochem Soc Trans. 13:122-3
- Trejdosiewicz et al. 1985. J Urol. 133(3):533-8. PMID: 2579255.
- Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization.
